Home >

Contract Manufacturing

Any company that serves the pharma industry on a contract basis to provide services from drug development through manufacturing. Content in this section will discuss the increasingly vital role of outsourcers such as CMOs, CDMOS, and CROS in pharma’s supply chain.

Articles

Piramal opens oral solid dosage suite in Pennsylvania for NewAmsterdam

The Sellersville site expansion will support production of NewAmsterdam Pharma’s investigational fixed-dose combination cholesterol therapy.

WuXi Biologics reports 2025 growth with expanded services, new capacity

The Chinese CRDMO attributed the results in the first half of 2025 to operational efficiency gains, technology platform expansion, and facility ramp-ups in Europe.

Upperton Pharma Solutions, Oxford University partner to advance oral vaccine formulation

The UK-based CDMO will contribute formulation expertise to a project aimed at addressing the limitations of intramuscular vaccine administration.

American Injectables expands its FDA-approved sterile fill-finish facility

The expansion adds aseptic lines for syringes and vials, formulation and R&D capacity, and commercial-scale packaging capabilities at its Brooksville, Florida site.

Oxford Biomedica expands US capacity to meet viral vector demand

The $78 million investment will support large-scale GMP production, fill-finish, and advanced automation.

News

ProBio launches cGMP AAV manufacturing at New Jersey facility

Made Scientific opens GMP cell therapy facility in New Jersey

WuXi Biologics achieves pilot-scale automated continuous drug substance production

Bionova opens Texas pDNA facility to expand cell and gene therapy support

WuXi Biologics launches stable cell line platform for development, manufacturing

Sumitomo’s CDMO to double regenerative medicine manufacturing capacity

WuXi XDC boosts sterile drug product capacity with new China facility

The Chinese CRDMO’s newest GMP-compliant facility in Wuxi adds seven million vials of annual capacity, expanding its bioconjugate drug product network.

Bora expands Minnesota site with roller compactor and new OSD capacity

The Taiwan-based pharmaceutical CDMO is investing in facility upgrades following its $210 million acquisition of Upsher-Smith Laboratories.

Esteve expands CDMO footprint with Regis Technologies acquisition

The deal marks Barcelona-based Esteve’s entry into the U.S. market for small-molecule API development and manufacturing.

ViroCell collaborates with AvenCell to support investigational cell therapy

The CDMO’s retroviral vector will be used to manufacture AvenCell’s investigational dual-targeted therapy for B cell malignancies and autoimmune diseases.

Expanding and scaling up pharma CDMO facilities

With a promising rate of growth, outsourcing partners of the future are rising to the challenge of a transforming industry

INCOG Biopharma: Pedaling towards excellence

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

Cellares: A disruptive impact on cell therapy

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

ten23 health: Sustainable success

With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Raising a modern pharma CDMO

Four young companies built with intention tackle the future of medicine

Meeting biopharma’s infrastructure demands

Biopharma facilities must address the specific needs and concerns of this dynamic sector